-
Jeremie Calais
Oncology / HematologySUO 2024 Highlights on Prostate Cancer Research - 3 month(s) agoDear readers, In my final newsletter about prostate cancer at the SUO 25th Annual Meeting, I wanted to highlight a few studies that caught my…
Nuclear Medicine and Theranostics With Jeremie Calais, MD, MSc
Oncology / HematologyDr. Calais is a nuclear medicine physician who specializes in cancer imaging and theranostics. He is an associate professor at the David Geffen School of Medicine, director of the UCLA Theranostics Program, and director of the Clinical Research Program of the Ahmanson Translational Theranostics Division. He conducts investigator-initiated and industry-sponsored clinical trials of targeted molecular imaging and radio nuclide therapy.
-
Jeremie Calais
Oncology / HematologySupplemental Insights & Commentary From SUO 2024 - 3 month(s) agoDear readers, As we continue to receive knowledge from SUO 2024, I wanted to share a bit of supplemental research and commentary from colleagues that…
-
Jeremie Calais
Oncology / HematologyLuPSMA Response and Lutetium-177 Delivery at SUO 2024 - 3 month(s) agoDear readers, Today, I would like to highlight two hot topics discussed at the 25th annual meeting of the SUO. First, Mohamed Ahmad, MB, BCh,…
-
Jeremie Calais
Oncology / HematologySUO 2024 Highlights Nuclear Medicine and Theranostics for ccRCC - 3 month(s) agoDear readers, The 25th meeting of the SUO wrapped up yesterday, and with it came a plethora of enriching knowledge in urology. First, I would…
-
Jeremie Calais
Oncology / Hematology2024 PSMA Wrap-Up: Do the Differences in PET Agents Matter? - 1 year(s) agoDear readers, As I wrap up this series covering the 2024 prostate-specific membrane antigen (PSMA) Conference, I want to discuss some ground-breaking studies. The first…
-
Jeremie Calais
Oncology / HematologyWhen is the Ideal Time for RLT in Prostate Cancer Treatment? - 1 year(s) agoDear readers, This week, I want to highlight more content from the 2024 Pprostate-specific membrane antigen (PSMA) Conference. First, consider when the right time to…
-
Jeremie Calais
Oncology / HematologyUCSF 2024 PSMA Conference: Highlights From the Inaugural Meeting - 1 year(s) agoDear readers, In January, the University of California San Francisco School of Medicine hosted the inaugural prostate-specific membrane antigen (PSMA) Conference. The meeting focused on…
-
Jeremie Calais
Oncology / HematologyPCF 2023 Wrap-Up: EnzaP Trial Shows PSF in PSMA Targeting - 1 year(s) agoDear readers, In my final email about the Annual Prostate Cancer Foundation Scientific Retreat 2023, I want to highlight a few interesting studies presented at…
-
Jeremie Calais
Oncology / HematologyUpdates From the Prostate Cancer Foundation Retreat - 1 year(s) agoDear Readers, The Annual Prostate Cancer Foundation Scientific Retreat 2023 happened this weekend in Carlsbad, California. Although the retreat ended, plenty of practice-changing data will…
-
Jeremie Calais
Oncology / HematologyProstate Cancer Foundation Retreat: Happening Now - 1 year(s) agoDear Readers, This week, some of the best prostate cancer specialists in the world are meeting in Carlsbad, California for the annual Prostate Cancer Foundation…